Health Enhancement Products, Inc. (OTCBB:HEPI - News) is a health & wellness company engaged in the development of products comprised of pure, all-natural compounds that can be used as a dietary supplement and food additive. The Company's product is ProAlgaZyme® (PAZ™), a liquid product drawn from living algae grown in purified water. The water in which the algae are grown is drawn off, filtered and bottled under the trademark ProAlgaZyme®.

HEPI is focused on isolating and identifying the active cholesterol agents present in PAZ. A study conducted during summer 2009 at Wayne State University's Department of Nutrition and Food Science by Dr. Smiti Gupta demonstrated unequivocally that PAZ filtrates are able to lower LDL cholesterol while raising HDL cholesterol in animal subjects. This bolsters previous studies that indicated similar results in humans and animals, albeit not under the strict conditions imposed by the  Wayne State University study.

100% Natural Products for Total Body Health, The Way Nature Intended.

Health Enhancement Products, Inc. (HEPI) is directed specifically at the selection and marketing of only the best of natural and herbal products including ProAlgaZyme®.

This direction arises from our convictions that:

 - the body is the strongest healing force known to mankind
 - proper diet, exercise, and medication are the best means of keeping the human body's healing powers at their best
 - the best medication is that which comes from natural sources, and which protect the body from harmful side-effects.

It is the mission of Health Enhancement Products, Inc. to develop health through science, products that are:

 - natural or derived from naturally-occurring materials -- without reliance on synthetics;
 - based on all-natural herbal extracts and botanical derivatives;
 - sold as foods and dietary supplements to promote wellness;
 - of premium quality.

With this primary mission, the Company will continue to seek products to either create and fulfill a marketing opportunity, offering substantial value for price, and which encourage customers to continue to enjoy good health through science.

The Company pursues multi-faceted research into health issues relevant to its products, and supports on-going clinical and academic research efforts wherever practicable.

The Company will also act with full responsibility to its investors and shareholders, and will seek opportunities consistent with the goals set above, to maximize shareholder benefit and deliver improved health through science.

Health Enhancement Products Inc.
7740 East Evans Road
Suite A101
Scottsdale, AZ 85260
United States - Map
Phone: 480-385-3800
Fax: 480-385-3801
Website: www.heponline.com

Health Enhancement Products Inc. Official Website

Health Enhancement Products, Inc. Receives 'Notice of Allowance' from US Patent Office for its Proprietary Algae Extract (Thursday, June 3rd, 2010)
Health Enhancement Products Announces Details of Its June 8th Scientific Panel Presentation (Wednesday, May 26th, 2010)
Health Enhancement Products Schedules Press Event June 8 to Present Breakthroughs in Its Cholesterol Management Research (Tuesday, May 11h, 2010)

Safe Harbor disclaimer: Certain statements contained herein constitute forward-looking statements within the meaning of Section 27Aof the Securities Act and Section 21E of the Exchange Act. Such statements include, without limitation, statements regarding business and financing plans, business trends and future operating revenues and expenses. Although the company believes that the statements are reasonable, it can give no assurance that such expecta- tions will prove to be correct. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate and similar expressions, or which by their nature refer to future events. The company cautions investors that any forward-looking statements made by the company are not guarantees of future performance, and that the actual results may differ materially from those in the forward-looking statements as a result of vari- ous factors, including but not limited to, the company’s ability to continue its projected growth, or to be able to fully implement its business strategies.

This profile is not without bias, and is a paid release. investingnewsalerts.com has been compensated for dissemination of company information on behalf of a third party. investingnewsalerts.com has been compensated 100,000 warrants  for coverage of this stock, by a third party, for services provided including dissemination of company information in this release. investingnewsalerts.com holds no shares of the stock. investingnewsalerts.com may receive shares for extension of its services. Any shares will be disclosed at such time that investingnewsalerts.com is aware of a clients desire to extend the original services. investingnewsalerts.com may have received shares of a company profiled in this release prior to the dissemination of the information in this release. investingnewsalerts.com may immediately sell some or any shares in a profiled company held by investingnewsalerts.com and may have previously sold shares in a profiled company held by investingnewsalerts.com. investingnewsalerts.com's services for a company may cause the company's stock price to increase, in which event investornewsalerts.com would make a profit when it sells its stock in a company. In addition, investingnewsalerts.com's selling of a company's stock may have a negative effect on the market price of the stock.

Got question, found problem? - info@investingnewsalerts.com